oxamniquine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| quinoline derivatives | 2009 | 21738-42-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 1 | g | O |
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| July 23, 1980 | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | P02BA02 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTHELMINTICS ANTITREMATODALS Quinoline derivatives and related substances |
| FDA EPC | N0000175481 | Anthelmintic |
| MeSH PA | D000871 | Anthelmintics |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000980 | Antiplatyhelmintic Agents |
| MeSH PA | D012556 | Schistosomicides |
| CHEBI has role | CHEBI:38941 | schistosomicide drugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Infection by Schistosoma | indication | 10087007 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.6 | Basic |
| pKa2 | 3.38 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| 4018629 | VUID |
| N0000146942 | NUI |
| D00460 | KEGG_DRUG |
| 4018629 | VANDF |
| C0029994 | UMLSCUI |
| CHEBI:7819 | CHEBI |
| OAQ | PDB_CHEM_ID |
| CHEMBL847 | ChEMBL_ID |
| DB01096 | DRUGBANK_ID |
| D010073 | MESH_DESCRIPTOR_UI |
| 4612 | PUBCHEM_CID |
| 3297 | INN_ID |
| 0O977R722D | UNII |
| 7778 | RXNORM |
| 5208 | MMSL |
| d01127 | MMSL |
| 002965 | NDDF |
| 714023005 | SNOMEDCT_US |
| 747006 | SNOMEDCT_US |
Pharmaceutical products:
None